We all know that healthcare expenditures are high and agree that something must happen to help lower the rising cost of prescription drugs. Congress is allowing the Centers for Medicare & Medicaid Services to negotiate prescription drug pricing.Unfortunately, what the bill is proposing isn’t a negotiation. The way the law is written, Medicare can set the price, and if it’s not agreed upon, they can impose a crippling penalty. This will likely impact the research and development of new drugs since it will take longer and be more difficult for a company to recover the money it must spend on R&D.